J&J COVID-19 vaccine candidate yields strong immune response in early trial
Immune response results were available from only 15 people over 65 years old, limiting the interpretation
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ad26.COV2.S
UK signs deals with J&J, Novavax for COVID-19 vaccine supplies
The latest agreements bring Britain’s total number of doses secured to 362 million for a population of 66 million
J&J signs pact with US for 100 million doses of COVID-19 vaccine
The US government is committing over $1 billion for this agreement